Thermo Fisher

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Laboratories • Critical Diagnostics • Epigenomics • Genomic Health • ICON plc • Laboratory Corporation of America Holdings • MDxHealth (formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana …

Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts | PR Newswire | 12/4/2019

LEXINGTON, Mass. , Dec. 4, Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization) site in Lexington, Mass. The 50,000-square-foot facility will add more than 200 jobs and support the development, testing and manufacture of viral vectors, which are critical to advancing new life-saving gene and cell therapies globally. “ Thermo Fisher’s investment in …

Follow Thermo Fisher:    

Worldwide Microscopy Markets to 2024 with Profiles on Leading Industry Players: Hitachi High Technologies, Jasco International, MIS, Nikon, Thermo Fisher Scientific, and More | Globe Newswire | 12/4/2019

… size and financial performance, ownership, and market shares Relevant patent analysis Company profiles of leading market participants within the industry, including Hitachi High Technologies Corp., Jasco International Co. Ltd., MIS Inc., Nikon Corp., and Thermo Fisher Scientific Inc. Key Topics Covered …

Global $8.2Bn Hematology Testing Market 2019-2029: Focus on Product Type, End-user, 11 Countries’ Data, and Competitive Landscape - ResearchAndMarkets.com | Business & Finance | manchestertimes.com | Business Wire | 12/4/2019

… Laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Danaher Corporation, Drew Scientific, EKF Diagnostics, F. Hoffmann-La Roche Ltd, HORIBA, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd. Key Topics Covered …

Meningitis Diagnosis and Treatment Market Trends, Growth Opportunities, SWOT Analysis to 2027 – B. Braun Melsungen, Sanofi, Pfizer, Siemens, GlaxoSmithKline, Merck, Baxter, Abbott, Bio-Rad, Thermo Fisher | 12/3/2019

Press Releases Meningitis Diagnosis and Treatment Market Trends, Growth Opportunities, SWOT Analysis to 2027 – B. Braun Melsungen, Sanofi, Pfizer, Siemens, GlaxoSmithKline, Merck, Baxter, Abbott, Bio-Rad, Thermo Fisher Meningitis is an inflammatory action that occurs in the inner lining of the brain and spinal cord resulting from infectious or non - infectious factors. This can cause critical brain damage if untreated and could lead to ailments such as mental retardation, epilepsy …

Thermo Fisher Rides on New Product Suite and Global Growth - December 3, 2019 - Zacks.com | 12/3/2019

Recently, we issued an updated research report on Thermo Fisher Scientific, Inc. ( TMO - Free Report ) . The company is rapidly ramping up its inorganic growth profile, the recent takeover being that of Brammer Bio. Its strong focus on the emerging markets is also encouraging. The stock has a Zacks Rank 2 (Buy). Over the past year, Thermo Fisher has successfully outperformed its industry . The stock has surged 30.3% versus the industry’s …

Coagulation Testing Market Global Outlook, Size, Scenario, Future Insights to 2027 – Abbott, NIHON KOHDEN, Hoffmann-La Roche, Thermo Fisher, Sysmex, Diagnostica Stago Sas, Coagulation, Helena, Medtronic, Micropoint | 12/3/2019

Press Releases Coagulation Testing Market Global Outlook, Size, Scenario, Future Insights to 2027 – Abbott, NIHON KOHDEN, Hoffmann-La Roche, Thermo Fisher, Sysmex, Diagnostica Stago Sas, Coagulation, Helena, Medtronic, Micropoint Coagulation Tests are primarily carried out by a coagulometer that measures and evaluates the speed of clot formation or blood coagulation and are basically employed to test the hemostasis system. These tests help in avoiding the chances of heart attack, thrombosis …

Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility | 12/3/2019

Press Releases Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility Thermo Fisher Scientific, the world leader in serving science, unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the site’s laboratory and warehousing capacity for upstream process development and quality control testing of gene therapy products. The expansion at the Alachua facility is part of …

Waratah Capital Advisors Ltd. Sells 74,121 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) | Daily Political | 12/3/2019

Adams Resources & Energy Inc to Issue Dividend of $0.24 (NYSEAMERICAN:AE) Waratah Capital Advisors Ltd. Sells 74,121 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) December 3rd, 2019 - Comments Off on Waratah Capital Advisors Ltd. Sells 74,121 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - Filed Under - by Trevor Kearing Tweet Waratah Capital Advisors Ltd. decreased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 60.4% during …

Waratah Capital Advisors Ltd. Has $14.16 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - American Banking News | 12/3/2019

Waratah Capital Advisors Ltd. trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 60.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,604 shares of the medical research company’s stock after selling 74,121 shares during the period. Thermo Fisher Scientific comprises about 1.6% of Waratah Capital Advisors Ltd.’s investment portfolio, making the stock its 18th …

Beck Bode LLC Has $7.03 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - TheOlympiaReport | 12/3/2019

Beck Bode LLC decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,144 shares of the medical research company’s stock after selling 159 shares during the quarter. Thermo Fisher Scientific comprises 3.1% of Beck Bode LLC’s holdings, making the stock its …

Cryo-EM structure of a 40 kDa SAM-IV riboswitch RNA at 3.7 Å resolution | Nature | 12/3/2019

Specimens below 50 kDa have generally been considered too small to be analyzed by single-particle cryo-electron microscopy (cryo-EM). The high flexibility of pure RNAs makes it difficult to obtain high-resolution structures by cryo-EM. In bacteria, riboswitches regulate sulfur metabolism through binding to the S-adenosylmethionine (SAM) ligand and offer compelling targets for new antibiotics. SAM-I, SAM-I/IV, and SAM-IV are the three …

Inflammatory Bowel Disease Treatment Market Research By Agilent Technologies, Inc., Thermo Fisher Scientific, Hitachi, Ltd., Shimadzu Corporation, PerkinElmer Inc., Hach, Beckman Coulter, Inc., PG Instruments Limited, JASCO, B&W Tek and Others | 12/3/2019

Press Releases Inflammatory Bowel Disease Treatment Market Research By Agilent Technologies, Inc., Thermo Fisher Scientific, Hitachi, Ltd., Shimadzu Corporation, PerkinElmer Inc., Hach, Beckman Coulter, Inc., PG Instruments Limited, JASCO, B&W Tek and Others Global Inflammatory Bowel Disease Treatment market report has been generated with the inputs from a team of experts based on detailed market analysis. This market report contains insights about market definition, classifications, applications, and engagements. This …

Infertility Treatment Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast By Esco Micro Pte Ltd., Genea Limited., Hamilton Thorne, Inc., Cook, Ivftech Aps, Fujifilm Irvine Scientific, Medgyn Products, Inc., Thermo Fisher Scientific Inc, The Cooper Companies Inc, Vitrolife And Others | 12/3/2019

Press Releases Infertility Treatment Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast By Esco Micro Pte Ltd., Genea Limited., Hamilton Thorne, Inc., Cook, Ivftech Aps, Fujifilm Irvine Scientific, Medgyn Products, Inc., Thermo Fisher Scientific Inc, The Cooper Companies Inc, Vitrolife And Others While formulating this Infertility Treatment market research report, marketing administration has carefully considered the minds of their target markets, their feelings, their preferences, their attitudes …

MedGenome, Thermo Fisher Array for South Asians to Support Consumer, MDx Test Development | 12/3/2019

Justin Petrone Premium NEW YORK – MedGenome has partnered with Thermo Fisher Scientific to genotype hundreds of thousands of South Asian cohorts using a custom genotyping array. The personalized medicine company hopes to use the new array to inform new consumer and clinical tests, while also making it available to others for research. “The limitation in South Asia has been that there are no genotyping array platforms that were optimized for …

Global Mass Spectrometry Market Outlook to 2024 - Growing Opportunities in Emerging Markets | PR Newswire | 12/2/2019

… market is projected to reach USD 6,313.7 million by 2024 from USD 4,569.1 million in 2019, rising at a CAGR of 6.7%. The major players in the market include SCIEX (US), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), PerkinElmer (US), Shimadzu Corporation ( Japan ), Bruker (US), Analytik Jena ( Germany ), JEOL ( Japan ), Rigaku ( Japan ), DANI Instruments ( Italy ), LECO (US) , Hiden Analytical (UK), Kore Technology (UK), Extrel CMS (US), MassTech …

The Zacks Analyst Blog Highlights: Procter & Gamble, Thermo Fisher, PayPal, NextEra Energy and Enterprise Products | 12/2/2019

… the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:Procter & Gamble ( PG - Free Report ) , Thermo Fisher ( TMO - Free Report ) , PayPal ( PYPL - Free Report ) , NextEra Energy ( NEE - Free Report ) and Enterprise Products ( EPD - Free Report ) . Here are highlights from Friday’s Analyst Blog: Top Analyst Reports for Procter & Gamble, Thermo Fisher and …

Bioinformatics Services Market Analysis of Rising Business Opportunities with Prominent Investment Ratio by 2027 | Thermo Fisher Scientific, Illumina, PerkinElmer, BGI, Source BioScience, QIAGEN | 12/2/2019

Press Releases Bioinformatics Services Market Analysis of Rising Business Opportunities with Prominent Investment Ratio by 2027 Thermo Fisher Scientific, Illumina, PerkinElmer, BGI, Source BioScience, QIAGEN The report on “Bioinformatics Services Market” will help Major Players and the new entrants to understand scrutinize the market in detail. This information will encourage the Major Players to decide their business strategy and achieve proposed business aims. Bioinformatics services involves the development of tools …

Genetic Engineering Market Size, Trends, Analysis And Industry Overview Till 2027 – Integrated DNA, Thermo Fisher, Merck, Horizon, Transposagen, New England, Genscript, Lonza, Origene, Sangamo | 12/2/2019

… players and offers key trends and opportunities in the market. Get Sample PDF For More Professional And Technical Insights at: https://www.premiummarketinsights.com/sample/TIP00014248 The List of Companies,,1. Integrated DNA Technologies, Inc.,2. Thermo Fisher Scientific Inc.,3. Merck KGaA,4. Horizon Discovery Group Plc.,5. Transposagen Biopharmaceuticals Inc.,6. New England Biolabs,7. Genscript Biotech Corporation,8. Lonza Group,9. Origene Technologies, Inc.,10. Sangamo Therapeutics, Inc. The …

Dengue Virus Diagnostic Tests Market Global Analysis and Forecasts 2027 | Arkray, Ceres Nanosciences, Abbott, Quest Diagnostics, F. Hoffmann-La Roche, Thermo Fisher Scientific | 12/2/2019

Press Releases Dengue Virus Diagnostic Tests Market Global Analysis and Forecasts 2027 Arkray, Ceres Nanosciences, Abbott, Quest Diagnostics, F. Hoffmann-La Roche, Thermo Fisher Scientific The report on “Dengue Virus Diagnostic Tests Market” will help Major Players and the new entrants to understand scrutinize the market in detail. This information will encourage the Major Players to decide their business strategy and achieve proposed business aims. Dengue is a disease caused …

Medical Research

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … LightArray Biotech M2Gen Mayo Clinic [US] Mayo Collaborative Services MDxHealth Medical Research Council [UK] MediMedia Pharma Solutions Memorial Sloan-Kettering Cancer Center [US] Merck & Co. Merck KGaA Metabolon Michael J Fox Foundation Myriad Genetics Myriad …

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Inflammation Centogene Centre For Proteomic & Genomic Research Chan Soon-Shiong Institute of Molecular Medicine Children’s Hospital of Orange County Children’s Medical Research Institute Children’s Hospital Colorado Chugai Pharmaceutical Cisbio Bioassays Codexis Core Diagnostics India COTA … Tetragenetics The Hospital for Sick Children Theranostics Health Therapure Biopharma Thermo Fisher Scientific TME Research Transgenomic Translational Drug Development UCB University of British Columbia University of California San Francisco University of Florida University of Greifswald …

Biotech

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Crelux Critical Diagnostics Critical Path Institute (C-Path) [US] CTI Biotech Daiichi Sankyo Dako (now part of Agilent) Dana-Farber Cancer Institute [US] Danaher DaVita Labs DiaGenic Durin Technologies DxS (now part of QIAGEN) EKO …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… 2014-2019: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Most of the deals included within the report occur when a … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Clinical Diagnostics

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

… technological advancements and growing demand for rapid diagnostic tests. However, factors like the high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and … Healthcare) Merck Kgaa Promega Corporation Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Molecular Diagnostics for Cancer - Worldwide Markets, Strategies & Trends, Forecasts by Cancer Type & Country (2020-2024) | Globe Newswire | 12/4/2019

… India Invitae Q3 Revenues More Than Double Illumina to Acquire Pacific Biosciences Lung Cancer Panel From PlexBio Receives CE Mark Thermo Fisher Scientific Gets CE-IVD Mark for Oncomine Dx Merck KGaA, ArcherDx Partner to … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

Genomics

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Biomarkers • Efficacy Biomarkers • Validation Biomarkers • This report also breaks down the revenue forecast for the global biomarkers market by Discipline: • Genomics • Proteomics • Bioinformatics • Other • This report also breaks down the revenue forecast for the global … Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Agency Avion Pharmaceuticals Aytu BioScience Back Bay Scientific Bavarian Nordic Bayer Bayer Healthcare Baylor College of Medicine Beckman Coulter Beijing Genomics Institute (BGI) Besins Healthcare Bill and Melinda Gates Foundation Biocon Biomnis Biotech Inc BL … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Diagnostic Tests

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … 2019-2029 Global Precision Medicine Market Forecast 2019-2029 Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 Global Protein Expression Market Forecast to 2029 SOURCE Visiongain …

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

… the field of companion diagnostics using PCR, increasing qPCR based food safety testing, technological advancements and growing demand for rapid diagnostic tests. However, factors like the high cost of commercial PCR assays in clinical diagnostics … Healthcare) Merck Kgaa Promega Corporation Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Precision Medicine

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … 2018-2028 Checkpoint Inhibitors for Anti-Cancer Treatment Market 2019-2029 Global Precision Medicine Market Forecast 2019-2029 Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 Global Protein Expression Market Forecast to 2029 SOURCE Visiongain …

Analysis on the World Market for Biomarkers 2016-2019 & 2025: Key Trends, Discovery Techniques & Applications | Globe Newswire | 12/4/2019

… Biosystems Ink Deal to Market Products for High Throughput Spatial Analysis New Immunoassay for Kratom Alkaloid Mitragynine Screening Introduced by Thermo Fisher Scientific Bio-Techne and NanoString in Collaboration to Develop Integrated Workflow for RNA … to Improve Cancer Immunotherapy Biomarker Discovery Thermo Fisher Scientific Opens Precision Medicine Science Center in The United States Myriad Genetics to Acquire Counsyl Thermo Fisher Scientific Inks Deal with Daiichi Sankyo and Takeda Pharmaceuticals to …

Gene Therapy

(USA-FL-Alachua) Lab Technician | 12/4/2019

Thermo Fisher Scientific Lab Technician in Alachua , Florida Job Description Position Description/Summary: Thermofisher Scientific is a dynamic organization that is looking for motivated scientists to develop the highest quality processes, analytics, and products to our clients. Our staff members; are committed to making a difference in our organization, to the cell and gene therapy field, for our client partners and the patients they serve. We seek individuals with proven …

Contract manufacturing in “tremendous” state as growth strains current capacity, CPhI delegates told | 12/4/2019

… M&A by large CMOs, panelist Anil Kane, executive director, global head of scientific and technical affairs, Patheon , part of Thermo Fisher Scientific (Waltham, MA, US) noted Thermo Fisher Scientific’s acquisition of Brammer Bio LLC … allow Thermo Fisher and Catalent to expand into cell and gene therapy. Interestingly, the acquisitions of Paragon and Brammer were predicted in a past Trend report (M&A in the Contract Manufacturing Industry: Implications and …

Molecular Diagnostics

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Biosciences Health Diagnostic Laboratory HealthLinx Helicos BioSciences Hewlett-Packard HTG Molecular Diagnostics ICON Plc Illumina ImmunId Insight Genetics Institute of Pathology Heidelberg (IPH) Integrated Diagnostics Ipsen Ipsogen (a subsidiary of QIAGEN) Isogen Life Science Johnson …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Start Genetics Grunenthal Guided Therapeutics Gynica Halt Medical Hammock Pharmaceuticals HealthNet Helix Helix BioPharma Hologic Hookipa Biotech Hope Medicine HTG Molecular Diagnostics Igantia Therapeutics iGenomix Illumina Imaxio IncellDx InnerOptic Technology Innovus Pharmaceuticals Inovio Pharmaceuticals Intuitive … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Regenerative Medicine

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Tasso Tennessee Hemophilia Terumo Thalassaemia International Federation The Medicines Company Thermo Fisher Scientific TNO Pharma Tokra Medikal Topas Therapeutics Turgut Ilaclari UCB Uniformed Services University of the Health Sciences University College Cork University of Bonn …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Tasso Tennessee Hemophilia Terumo Thalassaemia International Federation The Medicines Company Thermo Fisher Scientific TNO Pharma Tokra Medikal Topas Therapeutics Turgut Ilaclari UCB Uniformed Services University of the Health Sciences University College Cork University of Bonn …

NIH

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Aging ( NIA) [US] National Jewish Health [US] Newcastle University [UK] NIH (National Institute of Health) Oslo University Hospital Pharmaceutical Research and Manufacturers of America (PhRMA) Pharmaceuticals and Medical Devices Agency (PMDA) [ Japan ] Predictive Safety Testing …

Contract manufacturing in “tremendous” state as growth strains current capacity, CPhI delegates told | 12/4/2019

… M&A by large CMOs, panelist Anil Kane, executive director, global head of scientific and technical affairs, Patheon , part of Thermo Fisher Scientific (Waltham, MA, US) noted Thermo Fisher Scientific’s acquisition of Brammer Bio LLC … molecule, solid, oral dose products (B/POR, March 2019). The NIH has funded Continuus Pharma (Woburn, MA, US), a company that grew out of the Novartis-MIT Center for Continuous Manufacturing (Cambridge, MA, US), to …

Thermo Fisher Scientific

(USA-FL-Alachua) Lab Technician | 12/4/2019

Thermo Fisher Scientific Lab Technician in Alachua , Florida Job Description Position Description/Summary: Thermofisher Scientific is a dynamic organization that is looking for motivated scientists to develop the highest quality processes, analytics, and products to our clients. Our staff members; are committed to making a difference in our organization, to the cell and gene therapy field, for our client partners and the patients they serve. We seek individuals with proven …

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments …

Merck

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments …

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

Merck Kgaa Promega Corporation Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Qiagen

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the …

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Siemens

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … QIAGEN) Sandor Proteomic Sanger Institute Sanofi Santaris Pharma Servier Shionogi Siemens Siemens Healthcare Singulex Inc Sividion Diagnostics SMA Foundation [US] Stemina Biomarker Discovery Sysmex Technology Strategy Board (TSB) [UK] Teva Pharmaceutical Industries Thallion Pharmaceuticals The …

Molecular Diagnostics for Cancer - Worldwide Markets, Strategies & Trends, Forecasts by Cancer Type & Country (2020-2024) | Globe Newswire | 12/4/2019

… India Invitae Q3 Revenues More Than Double Illumina to Acquire Pacific Biosciences Lung Cancer Panel From PlexBio Receives CE Mark Thermo Fisher Scientific Gets CE-IVD Mark for Oncomine Dx Merck KGaA, ArcherDx Partner to … Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo Fisher Trovagene Vortex Biosciences 6. The Global Market for MDx Cancer 6.1 MDx Cancer - Global Market Overview …

GE Healthcare

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Sciences (part of Shionogi) FEI Company Foundation Medicine Fujirebio Diagnostics GE Healthcare Genetic Technologies Geneva Bioinformatics (GeneBio) Genomic Health GenWay Biotech Great Point Partners GSK HD Biosciences Health Diagnostic Laboratory HealthLinx Helicos BioSciences Hewlett-Packard …

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

… Ge Healthcare) Merck Kgaa Promega Corporation Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Abbott Laboratories

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments …

Polymerase Chain Reaction (PCR) Market - Global Forecast to 2025: Market is Expected to Reach $12.9 Billion - ResearchAndMarkets.com | Malvern Daily Record | 12/4/2019

… Abbott Laboratories, Inc. Agilent Technologies Becton Dickinson And Company Biomerieux Sa Bio-Rad Laboratories F.Hoffmann-La Roche Ltd (Roche Diagnostics) General Electric Company (Ge Healthcare) Merck Kgaa Promega Corporation Qiagen N.V. Takara Bio, Inc. Thermo Fisher Scientific, Inc. For more information about this report visit https://www.researchandmarkets.com/r/xnbnk0 …

Siemens Healthineers

Global Hematology Testing Market Outlook to 2029 - Advent of POC Hematology Testing Equipment Expected to Create a Market Boom in the Upcoming Years | Globe Newswire | 12/4/2019

… Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd. Key Topics Covered Executive Summary 1 Product Definition 2 Scope of the Work 2.1 Overview: Report Scope 2.2 Segmentation of the Global Hematology Testing Market 2.3 Assumptions and Limitations 2.4 Key Questions Answered in the Report 2.5 Base Year and Forecast Period 3 Research Methodology 3.1 Overview: Report Methodology 4 Global Hematology Testing Market 4.1 Market Overview …

Global Hematology Testing Market Outlook to 2029 - Advent of POC Hematology Testing Equipment Expected to Create a Market Boom in the Upcoming Years | Benzinga | 12/4/2019

… Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd. Key Topics Covered Executive Summary 1 Product Definition 2 Scope of the Work 2.1 Overview: Report Scope 2.2 Segmentation of the Global Hematology Testing Market 2.3 Assumptions and Limitations 2.4 Key Questions Answered in the Report 2.5 Base Year and Forecast Period 3 Research Methodology 3.1 Overview: Report Methodology 4 Global Hematology Testing Market 4.1 Market Overview …

Novartis

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments …

Contract manufacturing in “tremendous” state as growth strains current capacity, CPhI delegates told | 12/4/2019

… M&A by large CMOs, panelist Anil Kane, executive director, global head of scientific and technical affairs, Patheon , part of Thermo Fisher Scientific (Waltham, MA, US) noted Thermo Fisher Scientific’s acquisition of Brammer Bio LLC … Woburn, MA, US), a company that grew out of the Novartis-MIT Center for Continuous Manufacturing (Cambridge, MA, US), to develop machinery for continuous manufacturing, noted Miller. Continuous processing has challenges to adoption, Bikash Chatterjee …

Siemens Healthcare

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Sandor Proteomic Sanger Institute Sanofi Santaris Pharma Servier Shionogi Siemens Siemens Healthcare Singulex Inc Sividion Diagnostics SMA Foundation [US] Stemina Biomarker Discovery Sysmex Technology Strategy Board (TSB) [UK] Teva Pharmaceutical Industries Thallion Pharmaceuticals The Biomarkers …

Life Science Reagents Market Players Are Investing In Research Activities To Strengthen Their Position In The Market till 2028 | Radiant Insights, Inc. | 12/3/2019

Thermo Fisher Scientific • Merck Millipore • Abbott • BioMerieux • BD • Siemens Healthcare • Sysmex • Bio-Rad Laboratories • Lonza Group • Agilent Technologies • PerkinElmer • Meridian Life Science • Promega • Waters Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-life-science-reagents-market/request-sample Market split by Type, can be divided into: • Chromatography Reagents • IVD Diagnostics Reagents • PCR Reagent Kits • Cell & Tissue Culture Reagents • Others Market split by Application …

GSK

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments …

Visiongain Report Offers Transformative Insights on the $11bn Biological Drug API Manufacturing Market | PR Newswire | 12/3/2019

PRNewswire/ – The biological drug API manufacturing market is estimated to grow at a CAGR of 9.5% in the first half of the forecast period. In 2018, Mammalian cell culture systems submarket represents the largest submarket within the biological drug API manufacturing industry . How this 211-page Visiongain report delivers: • Biological Drug API Manufacturing Services market forecast to 2029 • Biological Drug API Manufacturing Services market forecast to 2029 by Expression Systems …

BlackRock Inc.

Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Lessened by Orbimed Advisors LLC | 11/30/2019

Orbimed Advisors LLC lessened its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 24.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional … after buying an additional 378,260 shares during the last quarter. BlackRock Inc. raised its stake in Thermo Fisher Scientific by 1.4% in the 2nd quarter. BlackRock Inc. now owns 27,643,905 shares of the medical research …

Select Equity Group L.P. Has $138.28 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - Ticker Report | 11/29/2019

Select Equity Group L.P. lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 12.1% during the third quarter, according to the company in its most recent Form 13F filing with the … 9,007,455,000 after purchasing an additional 378,260 shares during the period. BlackRock Inc. raised its position in Thermo Fisher Scientific by 1.4% in the 2nd quarter. BlackRock Inc. now owns 27,643,905 shares of the medical research …

OrbiMed Advisors

Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Lessened by Orbimed Advisors LLC | 11/30/2019

Orbimed Advisors LLC lessened its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 24.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 351,900 shares of the medical research company’s stock after selling 110,900 shares during the quarter. Thermo Fisher Scientific makes up approximately 1.9% of Orbimed Advisors LLC’s portfolio, making the stock its 14th largest …

Orbimed Advisors LLC Grows Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) | 9/29/2019

Orbimed Advisors LLC Grows Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) Posted by Renata Jones on Sep 28th, 2019 // Comments off Orbimed Advisors LLC raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 462,800 shares of the medical research company’s stock after purchasing an …

Jennison Associates

Paradigm Asset Management Co. LLC Decreases Position in Thermo Fisher Scientific Inc. (NYSE:TMO) | 11/29/2019

Paradigm Asset Management Co. LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 16.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with … after purchasing an additional 1,911,308 shares during the last quarter. Jennison Associates LLC lifted its stake in Thermo Fisher Scientific by 2,589.9% during the second quarter. Jennison Associates LLC now owns 819,138 shares of the …

Paradigm Asset Management Co. LLC Decreases Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - WKRB News | 11/29/2019

Paradigm Asset Management Co. LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 16.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with … after purchasing an additional 1,911,308 shares during the last quarter. Jennison Associates LLC lifted its stake in Thermo Fisher Scientific by 2,589.9% during the second quarter. Jennison Associates LLC now owns 819,138 shares of the …

Domain Associates

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Management Covance Covidien CR-CP Life Science Fund Creative Animodel Creative Biogene CureDuchenne Dana-Farber Cancer Institute Dharmacon Dicerna Pharmaceuticals Domain Associates EcoR1 Capital Eli Lilly Eurofins Genomics Eurogentec Exiqon Fidelity Biosciences FOCUS Media Jiangnanchun … The Alpha-1 Project The Medicines Company Tha Open Innovation Thermo Fisher Scientific TPG Biotech Transgene Biotek transOMIC technologies Transplant Genomics Stanford University University of California University of Pennsylvania University of Texas University of Virginia …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

… Management Covance Covidien CR-CP Life Science Fund Creative Animodel Creative Biogene CureDuchenne Dana-Farber Cancer Institute Dharmacon Dicerna Pharmaceuticals Domain Associates EcoR1 Capital Eli Lilly Eurofins Genomics Eurogentec Exiqon Fidelity Biosciences FOCUS Media Jiangnanchun … The Alpha-1 Project The Medicines Company Tha Open Innovation Thermo Fisher Scientific TPG Biotech Transgene Biotek transOMIC technologies Transplant Genomics Stanford University University of California University of Pennsylvania University of Texas University of Virginia …

Oxford Finance

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore Biopharma OriGene Technologies Oxford Finance Partner Fund Management PCI Biotech Pfizer Phio Pharmaceuticals (previously known as Rxi Pharmaceuticals … The Alpha-1 Project The Medicines Company Tha Open Innovation Thermo Fisher Scientific TPG Biotech Transgene Biotek transOMIC technologies Transplant Genomics Stanford University University of California University of Pennsylvania University of Texas University of Virginia …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

… National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore Biopharma OriGene Technologies Oxford Finance Partner Fund Management PCI Biotech Pfizer Phio Pharmaceuticals (previously known as Rxi Pharmaceuticals … The Alpha-1 Project The Medicines Company Tha Open Innovation Thermo Fisher Scientific TPG Biotech Transgene Biotek transOMIC technologies Transplant Genomics Stanford University University of California University of Pennsylvania University of Texas University of Virginia …

GreatPoint Ventures

Truvian nets $27M to build its comprehensive benchtop blood testing machine | FierceBiotech | 11/20/2019

… the San Diego-based company’s total funding to date up to $46.3 million. The series B round was led by GreatPoint Ventures with additional backing from DNS Capital, Tao Capital Partners and previous investor Domain … Meister has previously served as chairman of the board of Thermo Fisher Scientific and chairman and CEO of inVentiv Health. Read more on …

With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests | TechCrunch | 11/20/2019

Thermo Fisher Scientific board of directors, Paul Meister, as a new director. Funding for the company came from GreatPoint Ventures and included DNS Capital , Tao Capital Partners and previous investor Domain Associates . The ultimate goal, according to Hawkins, is to develop a system that can be installed in labs and can provide accurate results in 20 minutes for a battery of health tests from a small sample of blood for …

Zacks Equity Research

Canopy Growth (CGC) Q2 Earnings & Revenues Miss Estimates | Zacks | 11/18/2019

You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Canopy Growth Corporation ( CGC - Free Report ) incurred loss per … Inc ( RMD - Free Report ) , NuVasive, Inc ( NUVA - Free Report ) and Thermo Fisher Scientific Inc ( TMO - Free Report ) .ResMed, with a Zacks Rank 2 (Buy), reported first-quarter fiscal 2020 adjusted earnings per share (EPS) of …

The Zacks Analyst Blog Highlights: AMETEK, Thermo Fisher Scientific, IQVIA, Lowe’s Companies and Alexion Pharmaceuticals | 11/14/2019

Read More Hide Full Article For Immediate Release Chicago, IL – November 14, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AMETEK Inc. ( AME - Free Report ) , Thermo Fisher Scientific Inc. ( TMO - Free Report ) , IQVIA Holdings Inc. (IQV), Lowe’s Companies Inc. ( LOW …

Maxim Group

Stock Analysts’ Updated EPS Estimates for November, 14th (ABCZY, ACCO, ACRE, APYX, CY, MIST, RETA, TGNA, TMO, VBLT) | 11/15/2019

Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at Evercore ISI to an outperform rating. Vascular Biogenics (NASDAQ:VBLT) was upgraded by analysts at Chardan Capital from a neutral rating to a buy rating. VolitionRX (NYSEAMERICAN:VNRX) had its buy rating reissued by analysts at Maxim Group. They currently have a $8.00 target price on the stock. Walmart (NYSE:WMT) had its buy rating reaffirmed by analysts at Guggenheim …

Biolife Solutions Inc (BLFS) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… total revenue with 38% growth over Q3 last year. Key worldwide distributors for our media products include MilliporeSigma, STEMCELL Technologies, Thermo Fisher and VWR. Turning now to our other significant news of the day, we … First question comes from the line of Jason McCarthy of Maxim Group. Your line is now open. Dave – Maxim Group – Analyst Hi everyone, it’s Dave [Phonetic] on the line for Jason. So I don’t think …

Zacks Investment Research

QIAGEN (QGEN) Catches Eye: Stock Jumps 9.9% | Yahoo News | 11/14/2019

… as the stock is now up 30.9% in the past one-month time frame. The move came following reports that Thermo Fisher Scientific is considering a takeover of the company. The company has seen a … See their latest picks free Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report …

Zacks.com featured highlights include: SYNNEX, Thermo Fisher Scientific, Allstate, Intel and Target | 11/6/2019

… Article For Immediate Release Chicago, IL – November 6, 2019 - Stocks in this week’s article are SYNNEX Corp. ( SNX - Free Report ) , Thermo Fisher Scientific Inc. ( TMO - Free Report ) , The Allstate Corp. ( ALL - Free Report ) , Intel ( INTC … stocks-on-sale Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this …

Blackstone Group

Nov 14, 2019 - Sanders Morris Harris Inc. Buys Intuit Inc, Aimmune Therapeutics Inc, Verizon Communications Inc, Sells Dova Pharmaceuticals Inc, CenterPoint Energy Inc, CVS Health Corp - GuruFocus.com | 11/14/2019

… Shares reduced by 2.58% Main Street Capital Corp ( MAIN ) - 380,540 shares, 4.00% of the total portfolio. Shares reduced by 1.35% Blackstone Group Inc ( BX ) - 332,525 shares, 3.94% of the total portfolio. Shares added by 5.20 … 0.67%. The holding were 9 shares as of . New Purchase: Thermo Fisher Scientific Inc ( TMO ) Sanders Morris Harris Inc. initiated holding in Thermo Fisher Scientific Inc. The purchase prices were between $268.46 and $305.43, with …

Nov 14, 2019 - Mackenzie Financial Corp Buys Thermo Fisher Scientific Inc, Alcon Inc, Visa Inc, Sells iShares MSCI EAFE ETF, Allergan PLC, TELUS Corp - GuruFocus.com | 11/14/2019

Toronto Ontario, A6, based Investment company Mackenzie Financial Corp ( Current Portfolio ) buys Thermo Fisher Scientific Inc, Alcon Inc, Visa Inc, Vail Resorts Inc, Blackstone Group Inc, sells iShares MSCI EAFE ETF, Allergan PLC, TELUS Corp, Zoetis Inc, The Estee Lauder Inc during Mackenzie Financial Corp. As of 2019Q3, Mackenzie Financial Corp owns 995 stocks with a total value of $38 billion. New Purchases: ALC , MTN , BX , PS , CTVA , WYNN , PFF …

Mayo Clinic

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Leuven (University of Leuven) LabCorp Life Technologies LightArray Biotech M2Gen Mayo Clinic [US] Mayo Collaborative Services MDxHealth Medical Research Council [UK] MediMedia Pharma Solutions Memorial Sloan-Kettering Cancer Center [US] Merck & Co. Merck KGaA Metabolon …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Lee’s Pharmaceutical LFB Biotechnologies LifeHealth Ligand Pharmaceuticals Lonza Loop Medical Mallinckrodt Pharmaceuticals Massachusetts Institute of Technology Masterlab Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics … Tasso Tennessee Hemophilia Terumo Thalassaemia International Federation The Medicines Company Thermo Fisher Scientific TNO Pharma Tokra Medikal Topas Therapeutics Turgut Ilaclari UCB Uniformed Services University of the Health Sciences University College Cork University of Bonn …

MD Anderson Cancer Center

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Corporation of America Laccure Lake Consumer Products Lee’s Pharmaceutical LFB Biotechnologies LifeCodexx Lumara Health Lumir Lab Massachusetts General Hospital McKesson MD Anderson Cancer Center MDNA Life Sciences Meda MEDCIS Pathlabs Medical University of South Carolina … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Benzinga | 12/4/2019

… Corporation of America Laccure Lake Consumer Products Lee’s Pharmaceutical LFB Biotechnologies LifeCodexx Lumara Health Lumir Lab Massachusetts General Hospital McKesson MD Anderson Cancer Center MDNA Life Sciences Meda MEDCIS Pathlabs Medical University of South Carolina … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Massachusetts General Hospital

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of … Consortium (ICGC) Les entreprises du médicament (LEEM) [ France ] Malmö University Massachusetts General Hospital Max Planck Institute for Molecular Genetics [ Germany ] National Academy of Sciences National Cancer Institute (NCI) [US] National Health Service (NHS) [UK] National …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Therapeutics Kyoto University Laboratory Corporation of America Laccure Lake Consumer Products Lee’s Pharmaceutical LFB Biotechnologies LifeCodexx Lumara Health Lumir Lab Massachusetts General Hospital McKesson MD Anderson Cancer Center MDNA Life Sciences Meda MEDCIS Pathlabs Medical … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

Harvard Medical School

InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer | 11/19/2019

Thermo Fisher Scientific, and many years as Sr. VP and Head of the Roche Center for Medical Genomics, where he was intimately involved in Roche’s transition to becoming the first major personalized health care company. Previous to that, Klaus served as a faculty member at Harvard Medical School and the Harvard School of Public Health. “We finally have the quintessential scientific leader in Klaus. He will be working closely with …

HCA

WRL for Nov 2 | 11/2/2019

… 21 16.90% Corn ETF CORN 15.10 15.67 -2.01 ▲ 11 -1.01% Calamos Strategic TR Fund CSQ 13.05 12.51 0.68 ▲ 19 2.11% Healthcare Bull 3X ETF CURE 58.41 50.20 0.10 ▲ 0 0.00% Buy DB Agriculture ETF DBA … 1 -0.51% TJX Companies TJX 58.01 54.58 4.30 ▲ 9 6.13% Thermo Fisher Scientific TMO 303.60 278.14 1.22 ▲ 42 27.59% T-Mobile US TMUS 82.47 76.32 2.14 ▲ 43 22.41% Tapestry Inc TPR 26.29 27.75 -0.72 ▲ 55 …

Oct 31, 2019 - Zweig-DiMenna Associates LLC Buys Fidelity National Information Services Inc, Allergan PLC, First American Financial Corp, Sells Red Hat Inc, Array BioPharma Inc, Tableau Software Inc - GuruFocus.com | 10/31/2019

… Corp, Salesforce.com Inc, Everest Re Group, sells Red Hat Inc, Array BioPharma Inc, Tableau Software Inc, New York Times Co, Thermo Fisher Scientific Inc during the 3-months ended 2019Q3, according to the most recent … NYT , TMO , APC , EVBG , WWE , NXPI , HON , EA , CP , BYD , HCA , XLNX , RNG , ELAN , SWKS , LITE , MS , GTT , 5 Warning Signs with AGN. AGN AGN AGN For the details of Zweig-DiMenna Associates LLC’s stock …

Tenet Healthcare

WRL for Nov 2 | 11/2/2019

… 98.51 8.41 ▼ 23 31.84% Tiffany & Co TIF 127.00 89.79 3.77 ▲ 1 -0.51% TJX Companies TJX 58.01 54.58 4.30 ▲ 9 6.13% Thermo Fisher Scientific TMO 303.60 278.14 1.22 ▲ 42 27.59% T-Mobile US TMUS 82.47 76.32 … 1 -2.55% TEGNA Inc TGNA 15.23 14.55 0.88 ▲ 8 -4.03% Tenet Healthcare THC 25.88 21.35 2.43 ▲ 7 3.69% Hanover Insurance Group THG 129.59 127.40 1.72 ▼ 37 10.25% Thor Industries Inc THO 65.14 53.35 3.22 ▲ 2 …

Tracking Larry Robbins’ Glenview Capital Management Portfolio - Q1 2019 Update | Seeking Alpha | 6/6/2019

… increase at prices between $15.50 and $24.50. There was a ~44% reduction this quarter at prices between $16 and $27. Thermo Fisher Scientific ( TMO ): The 2.40% TMO position has been in the portfolio for over … further increase this quarter. The stock is now at $46.45. Tenet Healthcare ( THC ): THC is a 2.40% portfolio stake established in 2012 at a cost-basis in the low-20s. The original position saw a …

HCA Healthcare

Oct 31, 2019 - Cryder Capital Partners LLP Buys Charter Communications Inc, Microsoft Corp, Sells Cognizant Technology Solutions Corp, Alliance Data Systems Corp, Alphabet Inc - GuruFocus.com | 10/31/2019

Thermo Fisher Scientific Inc ( TMO ) - 414,088 shares, 15.49% of the total portfolio. Shares added by 3.35% HCA Healthcare Inc ( HCA ) - 896,753 shares, 13.86% of the total portfolio. Shares added by 9.96% Facebook Inc ( FB ) - 583,137 shares, 13.33% of the total portfolio. Shares reduced by 2.12% Alphabet Inc ( GOOG ) - 85,058 shares, 13.31% of the total portfolio. Shares added by 6.11% Charter Communications Inc ( CHTR ) - 221,119 shares, 11.70% of the total portfolio …

Acadia Healthcare downgraded to outperform from strong buy at Raymond James | MarketWatch | 7/31/2019

… Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher’s (TMO) analytical instruments revenues. Jul. 19, 2019 at 10:14 a.m. ET on Zacks.com … dampener. Jul. 15, 2019 at 8:40 a.m. ET on Zacks.com HCA Healthcare (HCA) acquires urgent care centers in Austin, Dallas and Houston to enhance its portfolio. Jul. 2, 2019 at 10:08 a.m. ET on Zacks.com …

One Medical

Global Cell Encapsulation Research Report 2019-2030 | PR Newswire | 10/30/2019

… Group for Clinical Cancer Research Sylvatica Biotech SymbioCellTech Symbiose Biomaterials Tactiva Therapeutics Taiwan Bio Therapeutics Takara Bio Takeda Pharmaceutical Targazyme TC BioPharm TCR2 Therapeutics Technocampus Group Tella Terumo Tessa Therapeutics Teva Pharmaceutical TheraCyte Thermo Fisher Scientific Thomas Jefferson University Tianhe Stem Cell Biotechnologies Tianjin Ever Union Biotechnology TiGenix TILT Biotherapeutics Tmunity Therapeutics TNK Therapeutics TotipotentRX TPG Capital TRACT Therapeutics TransCure BioServices Translational Drug Development Trinity College Dublin Triumvira Immunologics Tufts …

Global Medical Supplies Market Report 2019-2025: Overview, Focus on Select Players, Trends & Drivers, Global Market Perspective | PR Newswire | 10/30/2019

… research methodologies. Competitors identified in this market include: 3M Company B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson & Company Boston Scientific Corporation Cardinal Health, Inc. Halyard Health, Inc. Johnson & Johnson Medtronic PLC Thermo Fisher Scientific, Inc. Key Topics Covered: 1. Market Overview 2. Focus on Select Players 3. Market Trends & Drivers 4. Global Market Perspective For more information about this report visit https://www.researchandmarkets.com/r/rse7tx Research and Markets …

Tenet Healthcare Corporation

2019 Report: The Top 50 Global Companies for Health Care Equipment & Services | Benzinga | 10/24/2019

Thermo Fisher Scientific Inc. Shanghai Pharmaceuticals Holding Co Ltd Fujifilm Holdings Corporation Fresenius Medical Care AG & Co. KGaA Koninklijke Philips NV Wellcare Health Plans, Inc. Suzuken Co., Ltd. Danaher Corporation Molina Healthcare, Inc. Tenet Healthcare Corporation Siemens Healthineers Ag Becton Dickinson and Co Community Health Systems, Inc. Stryker Corporation Henry Schein, Inc. Jointown Pharmaceutical Group Co Ltd EssilorLuxottica SA Toho Holdings Company Limited Davita Inc Laboratory Corporation of America Holdings …

Top 50 Company Reports for Health Care Equipment & Services, 2019 - ResearchAndMarkets.com | Benzinga | 10/24/2019

Thermo Fisher Scientific Inc. Shanghai Pharmaceuticals Holding Co Ltd Fujifilm Holdings Corporation Fresenius Medical Care AG & Co. KGaA Koninklijke Philips NV Wellcare Health Plans, Inc. Suzuken Co., Ltd. Danaher Corporation Molina Healthcare, Inc. Tenet Healthcare Corporation Siemens Healthineers Ag Becton Dickinson and Co Community Health Systems, Inc. Stryker Corporation Henry Schein, Inc. Jointown Pharmaceutical Group Co Ltd EssilorLuxottica SA Toho Holdings Company Limited Davita Inc Laboratory Corporation of America Holdings …

Memorial Sloan Kettering Cancer Center

Novel Cell Sorting and Separation Markets, 2030 | PR Newswire | 10/7/2019

… Lupin Mackay Memorial Hospital Massachusetts Institute of Technology Mayo Clinic Foundation MD Anderson Cancer Center MDxK Medigen Biotech MeMed Diagnostics Memorial Sloan Kettering Cancer Center Menarini Silicon Biosystems Merck Metabiota Microbix Biosystems MicroMedicine Middle East … Cell The Fourth People’s Hospital of Chongqing Theranosis Life Sciences Thermo Fisher Scientific ThermoGenesis ThinkCyte Tisch Cancer Institute Tokai Pharmaceuticals TOMY Digital Biology TorpedoDx Tracon Pharmaceuticals Trinity College Dublin TumorGenesis Twist Bioscience Tyme UCB Biopharma …

The Alliance for Regenerative Medicine Announces Election of 2020 ARM Officers, Executive Committee, and Board of Directors | Financial Buzz | 10/2/2019

… Therapeutics (Chairman) Emile Nuwaysir, Ph.D. – President and CEO, BlueRock Therapeutics (Vice Chairman) Amy Butler, Ph.D. – VP and GM Cell Biology, Thermo Fisher Scientific (Secretary) Jeffrey Walsh, MBA – Chief Strategy Officer, bluebird bio (Treasurer) ARM 2020 … Isabelle Riviere, Ph.D. – Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center Jeff Ross, Ph.D. – CEO, Miromatrix Medical Mark Rothera, MBA – President & CEO, Orchard Therapeutics Curran Simpson, M.S. – SVP, Product Development and …

Humana

Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer | 11/27/2019

… to the manufacturer’s instruction. Then, the quality and quantity of total RNA were detected using a Thermo Scientific NanoDrop 2000 (Thermo Fisher Scientific, Inc., Wilmington, DE, USA). Subsequently, cDNA library was constructed following the manufacturer’s … edgeR,” in Methods in Molecular Biology , vol. 1418, p. 391, Humana Press, New York, NY, USA, 2016. View at Google Scholar G. Yu, L. G. Wang, Y. Han, and Q. Y. He, “clusterProfiler: an R …

Stocks That Hit 52-Week Highs On Tuesday | Benzinga | 11/26/2019

… LVMHF ) shares achieved a new 52-week high on Tuesday morning, hitting $450.00 with a daily change of up 0.45%. Thermo Fisher Scientific (NYSE: TMO ) shares achieved a new 52-week high on Tuesday morning … this morning. The stock was up 1.7% on the session. Humana (NYSE: HUM ) shares set a new 52-week high of $345.23 on Tuesday, moving down 0.16%. Alimentation Couche-Tard (OTC: ANCUF ) stock on Tuesday …

Cigna

WRL for Nov 2 | 11/2/2019

… Sell Charter Communications CHTR 476.48 394.14 7.64 ▲ 39 40.70% pP CH Robinson Worldwide CHRW 74.70 87.25 0.52 ▼ 0 0.00% Sell Cigna Corp CI 179.51 158.30 0.52 ▲ 1 4.56% Cincinnati Financial CINF 112.10 103.74 4.93 ▼ 66 … 1 -0.51% TJX Companies TJX 58.01 54.58 4.30 ▲ 9 6.13% Thermo Fisher Scientific TMO 303.60 278.14 1.22 ▲ 42 27.59% T-Mobile US TMUS 82.47 76.32 2.14 ▲ 43 22.41% Tapestry Inc TPR 26.29 27.75 -0.72 ▲ 55 …

Oct 31, 2019 - Veritas Asset Management LLP Buys Canadian Pacific Railway, MSC Industrial Direct Co Inc, HDFC Bank, Sells American Express Co, Cigna Corp, Microsoft Corp - GuruFocus.com | 10/31/2019

… Portfolio ) buys Canadian Pacific Railway, MSC Industrial Direct Co Inc, HDFC Bank, Yum China Holdings Inc, sells American Express Co, Cigna Corp, Microsoft Corp, CVS Health Corp, Dentsply Sirona Inc during the 3-months ended … shares, 7.89% of the total portfolio. Shares added by 3.74% Thermo Fisher Scientific Inc ( TMO ) - 2,679,227 shares, 7.60% of the total portfolio. Shares reduced by 1.56% Baxter International Inc ( BAX ) - 6,386,849 shares, 5.44% of the …

Aetna

Super PAC Backing ‘Middle-Class Joe’ Is Led by Lobbyists, Corporate Consultants, and Democratic Fundraisers | 10/31/2019

… and has contracted with Immigration and Customs Enforcement (ICE). Rasky Partners also lobbies in Massachusetts for Dell Computers, biotechnology company Thermo Fisher Scientific, and Toyota Motors of North America, and MasterCard. On its website , Rasky … a number of corporations and trade associations including Genentech, Intuit, Aetna, and PhRMA. Michèle Taylor, Board Member A former Democratic National Committee vice chair of finance, Democratic donor Taylor was appointed to the United States …

Will LabCorp’s (LH) Q2 Earnings Gain From Overall Growth? | Zacks | 7/22/2019

… quarter of 2019, banking on the following facts: First, January 2019 marked the official collaboration with UnitedHealthcare, Horizon NJ and Aetna, placing LabCorp in-network under all major national plans. Ever since, after a dip … the complete list of today’s Zacks 1 Rank stocks here . Thermo Fisher Scientific Inc. ( TMO - Free Report ) has an Earnings ESP of +0.54% and a Zacks Rank of 2. Stryker Corporation ( SYK - Free Report ) has …

Anthem

Company News For Oct 24, 2019 - October 24, 2019 - Zacks.com | 10/24/2019

Alexion Pharmaceuticals Inc.’s ( ALXN - Free Report ) shares soared 7.4% after reporting third-quarter 2020 adjusted earnings per share of $2.79, surpassing the Zacks Consensual Estimate of $2.49. Anthem Inc. ( ANTM - Free Report ) gained 1.3% after the company posted third-quarter 2019 adjusted earnings per share of $4.87, beating the Zacks Consensus Estimate of $4.84. Shares of Thermo Fisher Scientific Inc. ( TMO - Free Report ) surged 5.7% after posting third-quarter …

Sara Peerun

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… new report today you stay better informed and ready to act. To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-biomarkers … Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development …

Visiongain Report Offers Transformative Insights on the $11bn Biological Drug API Manufacturing Market | PR Newswire | 12/3/2019

… market forecast to 2029 • Biological Drug API Manufacturing Services market forecast to 2029 by Expression Systems: • Mammalian cell culture • Microbial fermentation • Other expression platforms To request sample pages from this report please contact Sara Peerun at or refer to our website: https://www.visiongain.com/report/biological-drug-api-manufacturing-services-world-industry-and-market-forecast-to-2029/ download_sampe_div • Biological Drug API Manufacturing Services market forecast to 2029 by Therapeutic …

Nihon Kohden

Global Hematology Testing Market Outlook to 2029 - Advent of POC Hematology Testing Equipment Expected to Create a Market Boom in the Upcoming Years | Globe Newswire | 12/4/2019

Nihon Kohden Corporation, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd. Key Topics Covered Executive Summary 1 Product Definition 2 Scope of the Work 2.1 Overview: Report Scope 2.2 Segmentation of the Global Hematology Testing Market 2.3 Assumptions and Limitations 2.4 Key Questions Answered in the Report 2.5 Base Year and Forecast Period 3 Research Methodology 3.1 Overview: Report Methodology 4 Global Hematology Testing Market …

Global Hematology Testing Market Outlook to 2029 - Advent of POC Hematology Testing Equipment Expected to Create a Market Boom in the Upcoming Years | Benzinga | 12/4/2019

Nihon Kohden Corporation, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd. Key Topics Covered Executive Summary 1 Product Definition 2 Scope of the Work 2.1 Overview: Report Scope 2.2 Segmentation of the Global Hematology Testing Market 2.3 Assumptions and Limitations 2.4 Key Questions Answered in the Report 2.5 Base Year and Forecast Period 3 Research Methodology 3.1 Overview: Report Methodology 4 Global Hematology Testing Market …

Charlie Baker

Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts | PR Newswire | 12/4/2019

LEXINGTON, Mass. , Dec. 4, Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization) site in Lexington, Mass. The 50,000-square … women will well serve Massachusetts and its communities,” said Governor Charlie Baker . “We look forward to working together to continue to build upon and strengthen the state’s role as a global leader in innovation.” Earlier …

Marc N. Casper

Waratah Capital Advisors Ltd. Sells 74,121 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) | Daily Political | 12/3/2019

Adams Resources & Energy Inc to Issue Dividend of $0.24 (NYSEAMERICAN:AE) Waratah Capital Advisors Ltd. Sells 74,121 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) December 3rd, 2019 - Comments Off on Waratah Capital Advisors Ltd … ratio is 6.83%. In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 2,271 shares of the business’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price …

Waratah Capital Advisors Ltd. Has $14.16 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - American Banking News | 12/3/2019

Waratah Capital Advisors Ltd. trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 60.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm … stock is undervalued. In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 47,729 shares of the company’s stock in a transaction on Friday, October 25th. The shares were sold at an average price …

Thierry Bernard

Why many bidders fight for Qiagen | 11/19/2019

… specialists. This may indicate a bidding war for the Hildener Group. The most promising candidate is still the American group Thermo Fisher Scientific, which has a similar structure to Qiagen – both in the diagnostics business … always seen as an advocate of the independence of Qiagen, Thierry Bernard took over as interim CEO, the leadership of the group. In response to these changes, the Qiagen share plummeted by more than a …

Thermo Fisher Rumored to Be Interested in Acquiring Qiagen | 11/15/2019

Waltham, MA-based Thermo Fisher Scientific could be acquiring Qiagen, according to a report from Bloomberg citing people with knowledge of the matter. IVD One of the biggest deals in diagnostics this year could be … technology. During the company’s 3Q19 conference call, Qiagen interim CEO Thierry Bernard spoke on the collaboration. “Joining forces with Illumina will enable us together to broaden the use of NGS in the clinical laboratories,” Bernard …

Donald Trump

Google Alert - testing | 11/17/2019

… previous compliance testing requirements … Flag as irrelevant White House: Trump undergoes tests during medical checkup PBS NewsHour BETHESDA, Md. — President Donald Trump spent more than two hours at Walter Reed National Medical Center on Saturday … Nebraska The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), … Flag as irrelevant You have received this email because you have subscribed to Google …

Research organization said that a program combining two separate | 11/15/2019

… the world’s biggest soccer clubs and has more than two million followers on social media. Qiagen soars on report of Thermo Fisher deal (For a live blog on European stocks, type LIVE/ in an Eikon … two previous Sexiest Man Alive holders have humorously responded. President Donald Trump’s 2016 campaign was keen to keep abreast of the release of emails potentially damaging to Democratic candidate Hillary Clinton, reaching all the way …

Marc Casper

Thermo Fisher Considers Buying $8 Billion Diagnostics Firm Qiagen | Yahoo News | 11/14/2019

Bloomberg) – Thermo Fisher Scientific Inc., the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV in what could become one of its biggest-ever acquisitions, people with knowledge of the … with the matter have said. Thermo Fisher Chief Executive Officer Marc Casper told analysts last month he feels “great” about the company’s mergers and acquisitions pipeline, which “continues to be very active.” Representatives for Thermo …

Qiagen Stock Jumps Bullishly On Rumored $8 Billion Thermo Fisher Buyout | Investor’s Business Daily | 11/14/2019

Qiagen stock popped in bullish volume Thursday on a report medical technology company Thermo Fisher Scientific ( TMO ) could buy it for $8 billion. X The Bloomberg report was published late Wednesday and cited people familiar … plenty of sense in our opinion as (Thermo Fisher CEO Marc Casper) and team can add Qiagen’s high-margin consumables directly onto the Fisher distribution chassis in addition to capturing plenty of bundling and synergy …

Mark Bamforth

Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply | Markets Insider | Business Insider | 11/13/2019

… Arranta, and we will be able to shepherd clients’ products through the clinical phases to commercial with our enhanced capabilities.” Mark Bamforth , founder, President and CEO at Arranta, said, “We welcome the team from Captozyme … Partners, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific. Arranta is establishing late-stage clinical and commercial-ready capacity at a new facility in Watertown, MA , which is scheduled to come …

Mike Rice

Biolife Solutions Inc (BLFS) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… view of our current financial results when compared to prior periods. Now, I’d like to turn the call over to Mike Rice, President and CEO BioLife. Mike Rice – Chief Executive Officer Thank you Rod, and … worldwide distributors for our media products include MilliporeSigma, STEMCELL Technologies, Thermo Fisher and VWR. Turning now to our other significant news of the day, we announced the acquisition of nearly all of the assets of …

BioLife Solutions Announces Third Quarter 2019 Financial Results | PR Newswire | 11/12/2019

… therapy contract manufacturer. Order volume from these two customers has resumed to typical levels to date in the fourth quarter. Mike Rice , BioLife Solutions CEO, remarked, “Q3 was another strong quarter of operational execution, growth … prior-year period. Key worldwide distributors include STEMCELL Technologies, MilliporeSigma, Thermo Fisher , VWR, World Courier and QuickStat. Third Quarter Operational Highlights Completed the acquisition of SAVSU Technologies, Inc. (“SAVSU”). Formed cell and gene therapy bioproduction …

Roderick de Greef

Biolife Solutions Inc (BLFS) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Roderick de Greef, Chief Financial Officer. You may begin. Roderick de Greef – Chief Financial Officer … worldwide distributors for our media products include MilliporeSigma, STEMCELL Technologies, Thermo Fisher and VWR. Turning now to our other significant news of the day, we announced the acquisition of nearly all of the assets of …

BioLife Solutions Announces Third Quarter 2019 Financial Results | PR Newswire | 11/12/2019

… representing 40% of total revenue with 38% growth over the prior-year period. Key worldwide distributors include STEMCELL Technologies, MilliporeSigma, Thermo Fisher , VWR, World Courier and QuickStat. Third Quarter Operational Highlights Completed the acquisition of … with $4.0 million for the first nine months of 2018. Roderick de Greef , BioLife Chief Financial Officer, remarked, “With the addition of CBS following the acquisitions of SAVSU and Astero earlier this year, along with …